These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 28401346)

  • 1. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
    Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
    Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-Mediated Gene Correction to Understand ALS.
    Yun Y; Ha Y
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis.
    Deneault E; Chaineau M; Nicouleau M; Castellanos Montiel MJ; Franco Flores AK; Haghi G; Chen CX; Abdian N; Shlaifer I; Beitel LK; Durcan TM
    Methods; 2022 Jul; 203():297-310. PubMed ID: 34500068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
    Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
    Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy in Amyotrophic Lateral Sclerosis.
    Fang T; Je G; Pacut P; Keyhanian K; Gao J; Ghasemi M
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
    Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
    Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.
    Ichiyanagi N; Fujimori K; Yano M; Ishihara-Fujisaki C; Sone T; Akiyama T; Okada Y; Akamatsu W; Matsumoto T; Ishikawa M; Nishimoto Y; Ishihara Y; Sakuma T; Yamamoto T; Tsuiji H; Suzuki N; Warita H; Aoki M; Okano H
    Stem Cell Reports; 2016 Apr; 6(4):496-510. PubMed ID: 26997647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
    Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
    Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Wide Analysis Points towards Subtype-Specific Diseases in Different Genetic Forms of Amyotrophic Lateral Sclerosis.
    Dash BP; Naumann M; Sterneckert J; Hermann A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR
    In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
    Gaj T; Ojala DS; Ekman FK; Byrne LC; Limsirichai P; Schaffer DV
    Sci Adv; 2017 Dec; 3(12):eaar3952. PubMed ID: 29279867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
    Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
    Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Duan W; Guo M; Yi L; Liu Y; Li Z; Ma Y; Zhang G; Liu Y; Bu H; Song X; Li C
    Gene Ther; 2020 Apr; 27(3-4):157-169. PubMed ID: 31819203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons.
    Lenzi J; De Santis R; de Turris V; Morlando M; Laneve P; Calvo A; Caliendo V; Chiò A; Rosa A; Bozzoni I
    Dis Model Mech; 2015 Jul; 8(7):755-66. PubMed ID: 26035390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis.
    Lanznaster D; Veyrat-Durebex C; Vourc'h P; Andres CR; Blasco H; Corcia P
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients.
    Jiang L; Tracey TJ; Gill MK; Howe SL; Power DT; Bharti V; McCombe PA; Henderson RD; Steyn FJ; Ngo ST
    Stem Cell Res; 2024 Aug; 78():103447. PubMed ID: 38796984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.